Loading clinical trials...
Loading clinical trials...
Prospective Randomized Double-blind Study Evaluating the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation
Conditions
Interventions
Vasopressin
Norepinephrine
+2 more
Locations
1
France
Chu Dijon Bourgogne
Dijon, France
Start Date
January 2, 2023
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
December 22, 2025
NCT06934798
NCT06539234
NCT03281317
NCT04054999
NCT06160219
NCT04668859
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions